2023 Family Conference: DIAN-TU Updates

Description: Updates on recent developments from the DIAN Trials Unit, with special focus on primary and secondary prevention trials, particularly those investigating the use of tau-targeting antibodies to treat Alzheimer’s disease
Runtime: 00:35:07

Speaker: Randall Bateman, MD
Speaker title: DIAN Trials Unit Director
Speaker organization: Washington University in St. Louis

Speaker: Eric McDade, DO
Speaker title: DIAN Trials Unit Co-Director
Speaker organization: Washington University in St. Louis

Event: 2023 Regional DIAD Family Conference: A New Era
Location: Amsterdam, Netherlands
Year: 2023

Search tags: biomarkers, preclinical Alzheimer’s, disease modification, primary prevention trials, DIAN-TU-001 Trial, DIAN-TU-002 Trial, DIAN history, disease progression, combination therapy, open-label extension, tau ASOs, siRNA, AAV vectors, secondary prevention trials, clinical trials, amyloid plaques, amyloid beta, gantenerumab, genetic therapies, APOE, anti-tau monoclonal antibodies, lecanemab, aducanumab, donanemab, research participation, Cognitive Run-In, presenilin, family planning, Youngtimers